Annual Current Liabilities
$21.83 M
+$14.50 M+197.76%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual total current liabilities is $21.83 million, with the most recent change of +$14.50 million (+197.76%) on December 31, 2023.
- During the last 3 years, IMNM annual current liabilities has risen by +$18.79 million (+618.53%).
- IMNM annual current liabilities is now at all-time high.
Performance
IMNM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$39.53 M
-$372.00 K-0.93%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly total current liabilities is $39.53 million, with the most recent change of -$372.00 thousand (-0.93%) on September 30, 2024.
- Over the past year, IMNM quarterly current liabilities has increased by +$17.70 million (+81.08%).
- IMNM quarterly current liabilities is now -0.93% below its all-time high of $39.90 million, reached on June 30, 2024.
Performance
IMNM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IMNM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +197.8% | +81.1% |
| 3 y3 years | +618.5% | +439.2% |
| 5 y5 years | +1298.4% | +439.2% |
IMNM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +197.8% | -0.9% | +439.2% |
| 5 y | 5-year | at high | +1211.0% | -0.9% | +2274.1% |
| alltime | all time | at high | +1298.4% | -0.9% | +2274.1% |
Immunome Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $39.53 M(-0.9%) |
| Jun 2024 | - | $39.90 M(+29.7%) |
| Mar 2024 | - | $30.77 M(+41.0%) |
| Dec 2023 | $21.83 M(+197.8%) | $21.83 M(-5.5%) |
| Sep 2023 | - | $23.11 M(-12.4%) |
| Jun 2023 | - | $26.39 M(+6.3%) |
| Mar 2023 | - | $24.83 M(+238.7%) |
| Dec 2022 | $7.33 M | $7.33 M(-0.5%) |
| Sep 2022 | - | $7.37 M(-14.5%) |
| Jun 2022 | - | $8.62 M(-11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $9.71 M(-0.2%) |
| Dec 2021 | $9.73 M(+220.2%) | $9.73 M(+25.3%) |
| Sep 2021 | - | $7.76 M(+120.5%) |
| Jun 2021 | - | $3.52 M(-23.0%) |
| Mar 2021 | - | $4.57 M(+50.5%) |
| Dec 2020 | $3.04 M(+82.5%) | $3.04 M(-43.8%) |
| Sep 2020 | - | $5.41 M(+93.8%) |
| Jun 2020 | - | $2.79 M(+67.5%) |
| Dec 2019 | $1.67 M(+6.7%) | $1.67 M |
| Dec 2018 | $1.56 M | - |
FAQ
- What is Immunome annual total current liabilities?
- What is the all time high annual current liabilities for Immunome?
- What is Immunome annual current liabilities year-on-year change?
- What is Immunome quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Immunome?
- What is Immunome quarterly current liabilities year-on-year change?
What is Immunome annual total current liabilities?
The current annual current liabilities of IMNM is $21.83 M
What is the all time high annual current liabilities for Immunome?
Immunome all-time high annual total current liabilities is $21.83 M
What is Immunome annual current liabilities year-on-year change?
Over the past year, IMNM annual total current liabilities has changed by +$14.50 M (+197.76%)
What is Immunome quarterly total current liabilities?
The current quarterly current liabilities of IMNM is $39.53 M
What is the all time high quarterly current liabilities for Immunome?
Immunome all-time high quarterly total current liabilities is $39.90 M
What is Immunome quarterly current liabilities year-on-year change?
Over the past year, IMNM quarterly total current liabilities has changed by +$17.70 M (+81.08%)